• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对城市流行性虫媒病毒的疫苗:现状

Vaccines Against Urban Epidemic Arboviruses: The State of the Art.

作者信息

Pereira Cláudio Antônio de Moura, Mendes Renata Pessôa Germano, Silva Poliana Gomes da, Chaves Elton José Ferreira, Pena Lindomar José

机构信息

Laboratory of Virology and Experimental Therapy (Lavite), Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), 50670-420 Recife, Brazil.

出版信息

Viruses. 2025 Mar 6;17(3):382. doi: 10.3390/v17030382.

DOI:10.3390/v17030382
PMID:40143310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11945797/
Abstract

Arboviruses represent a contemporary global challenge, prompting coordinated efforts from health organizations and governments worldwide. Dengue, chikungunya, and Zika viruses have become endemic in the tropics, resulting in the so-called "triple arbovirus epidemic". These viruses are transmitted typically through the bites of infected mosquitoes, especially and . These mosquito species are distributed across all continents and exhibit a high adaptive capacity in diverse environments. When combined with unplanned urbanization, uncontrolled population growth, and international travel-the so-called "triad of the modern world"-the maintenance and spread of these pathogens to new areas are favored. This review provides updated information on vaccine candidates targeting dengue, chikungunya, and Zika viruses. Additionally, we discuss the challenges, perspectives, and issues associated with their successful production, testing, and deployment within the context of public health.

摘要

虫媒病毒是当代全球面临的一项挑战,促使全球卫生组织和各国政府共同做出努力。登革热、基孔肯雅热和寨卡病毒已在热带地区成为地方病,导致了所谓的“虫媒病毒三重疫情”。这些病毒通常通过受感染蚊子的叮咬传播,尤其是 和 。这些蚊种分布于各大洲,并且在各种环境中都表现出很高的适应能力。当与无规划的城市化、不受控制的人口增长以及国际旅行(即所谓的“现代世界三要素”)相结合时,这些病原体在新地区的存续和传播就更为容易。本综述提供了有关针对登革热、基孔肯雅热和寨卡病毒的候选疫苗的最新信息。此外,我们还讨论了在公共卫生背景下,这些疫苗在成功生产、测试和部署方面所面临的挑战、前景及相关问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/4745a88eb195/viruses-17-00382-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/4fde0860b080/viruses-17-00382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/93116ecea4c4/viruses-17-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/5361a898154f/viruses-17-00382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/de2d65ba5bf1/viruses-17-00382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/c12213adada0/viruses-17-00382-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/4745a88eb195/viruses-17-00382-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/4fde0860b080/viruses-17-00382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/93116ecea4c4/viruses-17-00382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/5361a898154f/viruses-17-00382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/de2d65ba5bf1/viruses-17-00382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/c12213adada0/viruses-17-00382-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18e/11945797/4745a88eb195/viruses-17-00382-g006.jpg

相似文献

1
Vaccines Against Urban Epidemic Arboviruses: The State of the Art.针对城市流行性虫媒病毒的疫苗:现状
Viruses. 2025 Mar 6;17(3):382. doi: 10.3390/v17030382.
2
Significance of vertical transmission of arboviruses in mosquito-borne disease epidemiology.虫媒病毒垂直传播在蚊媒疾病流行病学中的意义。
Parasit Vectors. 2025 Apr 9;18(1):137. doi: 10.1186/s13071-025-06761-8.
3
Arboviruses: the hidden danger of the tropics.虫媒病毒:热带地区的隐藏危险。
Arch Virol. 2025 May 26;170(7):140. doi: 10.1007/s00705-025-06314-5.
4
Seroprevalence of Arboviruses in a Malaria Hyperendemic Area in Southern Mali.马里南部疟疾高度流行地区虫媒病毒血清流行率。
Am J Trop Med Hyg. 2024 Jun 4;111(1):107-112. doi: 10.4269/ajtmh.23-0803. Print 2024 Jul 3.
5
Effectiveness of environmental interventions to reduce entomological indices of dengue, Zika, and chikungunya vector.环境干预措施降低登革热、寨卡和基孔肯雅热媒介的昆虫学指标的效果。
Acta Trop. 2022 Sep;233:106523. doi: 10.1016/j.actatropica.2022.106523. Epub 2022 May 19.
6
Assessment of a multiplex arbovirus PCR Detection Test in an area endemic for Chikungunya, Zika, and Dengue viruses: An evaluation of kit performance characteristics in line with Clinical Laboratory Improvement Amendments (CLIA) Standards.在基孔肯雅病毒、寨卡病毒和登革热病毒流行地区对多重虫媒病毒PCR检测试验的评估:按照临床实验室改进修正案(CLIA)标准对试剂盒性能特征的评估。
PLoS One. 2025 Jun 24;20(6):e0309626. doi: 10.1371/journal.pone.0309626. eCollection 2025.
7
Rising Incidence and Spatiotemporal Dynamics of Emerging and Reemerging Arboviruses in Brazil.巴西新出现和再次出现的虫媒病毒的发病率上升及时空动态
Viruses. 2025 Jan 24;17(2):158. doi: 10.3390/v17020158.
8
Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.黄热病、登革热、寨卡病毒和基孔肯雅病毒疫苗研发的现状、挑战与前景
Acta Trop. 2018 Jun;182:257-263. doi: 10.1016/j.actatropica.2018.03.009. Epub 2018 Mar 15.
9
Sticky traps for Aedes aegypti surveillance and targeted vector control in Sincelejo, Colombia.用于哥伦比亚辛塞莱霍埃及伊蚊监测和目标性病媒控制的粘性诱捕器。
Biomedica. 2025 Mar 28;45(1):118-132. doi: 10.7705/biomedica.7290.
10
Human Urban Arboviruses Can Infect Wild Animals and Jump to Sylvatic Maintenance Cycles in South America.人类城市虫媒病毒可感染野生动物,并在南美洲跳转到丛林维持循环。
Front Cell Infect Microbiol. 2019 Jul 17;9:259. doi: 10.3389/fcimb.2019.00259. eCollection 2019.

引用本文的文献

1
Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses.黄病毒属和甲病毒属疫苗研发的最新进展
Vaccines (Basel). 2025 Jul 30;13(8):808. doi: 10.3390/vaccines13080808.
2
Mosquito Exosomal Tetraspanin CD151 Facilitates Flaviviral Transmission and Interacts with ZIKV and DENV2 Viral Proteins.蚊子外泌体四跨膜蛋白CD151促进黄病毒传播并与寨卡病毒和登革热病毒2型病毒蛋白相互作用。
Int J Mol Sci. 2025 Jul 31;26(15):7394. doi: 10.3390/ijms26157394.
3
Dengue virus modulates critical cell cycle regulatory proteins in human megakaryocyte cells.

本文引用的文献

1
Prophylactic and therapeutic vaccine development: advancements and challenges.预防性和治疗性疫苗的研发:进展与挑战。
Mol Biomed. 2024 Nov 11;5(1):57. doi: 10.1186/s43556-024-00222-x.
2
Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study.在美国,单剂接种活减毒基孔肯雅病毒疫苗后 2 年内的抗体持久性和安全性:一项单臂、多中心、3b 期研究。
Lancet Infect Dis. 2024 Dec;24(12):1383-1392. doi: 10.1016/S1473-3099(24)00357-8. Epub 2024 Aug 12.
3
Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia®) in the state of Paraná, Brazil: integrating case-cohort and case-control designs.
登革病毒调节人类巨核细胞中的关键细胞周期调节蛋白。
Sci Rep. 2025 May 30;15(1):19016. doi: 10.1038/s41598-025-02640-5.
巴西巴拉那州使用CYD-TDV(登革热疫苗,商品名:Dengvaxia®)进行大规模登革热疫苗接种的效果:病例队列与病例对照设计的整合
Lancet Reg Health Am. 2024 May 21;35:100777. doi: 10.1016/j.lana.2024.100777. eCollection 2024 Jul.
4
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets.寨卡纯化灭活病毒候选疫苗在孕期狨猴中的保护效力
NPJ Vaccines. 2024 Feb 17;9(1):35. doi: 10.1038/s41541-024-00824-0.
5
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice.寨卡纯化灭活病毒(ZPIV)疫苗降低了免疫功能正常的怀孕小鼠的垂直传播率。
NPJ Vaccines. 2024 Feb 15;9(1):32. doi: 10.1038/s41541-024-00823-1.
6
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.儿童和成人中使用减毒活、四价 Butantan-登革热疫苗。
N Engl J Med. 2024 Feb 1;390(5):397-408. doi: 10.1056/NEJMoa2301790.
7
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.四价登革热疫苗(TAK-003)的长期疗效和安全性:一项 3 期、随机、双盲、安慰剂对照试验的 4.5 年结果。
Lancet Glob Health. 2024 Feb;12(2):e257-e270. doi: 10.1016/S2214-109X(23)00522-3.
8
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults†.一项随机、双盲3期研究,旨在证明减毒活基孔肯雅病毒候选疫苗VLA1553在健康成年人中的批次间一致性,并确认其免疫原性和安全性† 。
J Travel Med. 2024 Mar 1;31(2). doi: 10.1093/jtm/taad156.
9
Increasing arbovirus risk in Chile and neighboring countries in the Southern Cone of South America.南美洲南锥体地区智利及周边国家的虫媒病毒风险不断增加。
Lancet Reg Health Am. 2023 Jun 23;23:100542. doi: 10.1016/j.lana.2023.100542. eCollection 2023 Jul.
10
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial.一种单次接种的减毒活寨卡病毒疫苗的安全性和免疫原性:一项双盲、多中心、随机、安慰剂对照、3 期临床试验。
Lancet. 2023 Jun 24;401(10394):2138-2147. doi: 10.1016/S0140-6736(23)00641-4. Epub 2023 Jun 12.